• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢性减肥手术后循环中长链非编码RNA p5549和p19461水平的变化:一项前瞻性研究

Changes in Circulating Levels of Long Non-Coding RNA p5549 and p19461 Following Metabolic Bariatric Surgery (MBS): A Prospective Study.

作者信息

Ammar Shaimaa, Abdelbaki Tamer, Elsabaa Bassma, El Assi Hoda, Kassem Heba

机构信息

Alexandria University, Alexandria, Egypt.

出版信息

Obes Surg. 2025 Jan;35(1):131-140. doi: 10.1007/s11695-024-07596-5. Epub 2024 Dec 9.

DOI:10.1007/s11695-024-07596-5
PMID:39652216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717812/
Abstract

BACKGROUND

Obesity is attributed to a combination of factors such as lifestyle, environmental influences, and genetic background. Nowadays, the issue of obesity has grown to an epidemic scale. Environmental changes, having contributed to the sharp rise in obesity prevalence, are not the only contributing etiologic factors. Inherent biological variables interact with environmental factors resulting in obesity. Epigenetic mechanisms may explain part of obesity heritability. One of the recently discovered epigenetic mechanisms for controlling gene expression is long non-coding RNAs (lncRNAs). Circulating lncRNA p5549 and p19461 levels were reported to be significantly lower in individuals with obesity. This study aimed to evaluate whether weight loss following metabolic/bariatric surgery (MBS) can be related to altered expression levels of those lncRNAs, which have been reported to be reduced in individuals with obesity.

METHODS

Comparison of circulating levels of lncRNA p5549 and p19461 before and 12 weeks after MBS in thirty-four patients was conducted to evaluate whether MBS can revert the altered levels of these lncRNAs. None of the participating patients were lost to follow-up, and all underwent re-evaluation of post-surgical expression levels.

RESULTS

lncRNA p5549 expression levels in serum were found to increase significantly in the postoperative samples compared to preoperative samples (fold increase: 4.63 ± 7.68, p = 0.014).

CONCLUSION

Epigenetic changes in patients with obesity, specifically lncRNA-p5549 expression levels, are reversed after MBS. The postoperative increase in the expression levels of lncRNA- p19461 was not statistically significant.

摘要

背景

肥胖归因于多种因素的综合作用,如生活方式、环境影响和遗传背景。如今,肥胖问题已发展到流行程度。环境变化促使肥胖患病率急剧上升,但并非唯一的致病因素。内在生物学变量与环境因素相互作用导致肥胖。表观遗传机制可能解释肥胖遗传性的部分原因。长链非编码RNA(lncRNAs)是最近发现的控制基因表达的表观遗传机制之一。据报道,肥胖个体中循环lncRNA p5549和p19461水平显著降低。本研究旨在评估代谢/减重手术(MBS)后体重减轻是否与这些lncRNAs表达水平的改变有关,据报道这些lncRNAs在肥胖个体中减少。

方法

对34例患者MBS术前和术后12周的lncRNA p5549和p19461循环水平进行比较,以评估MBS是否能恢复这些lncRNAs的改变水平。所有参与患者均未失访,且均接受了术后表达水平的重新评估。

结果

与术前样本相比,术后样本中血清lncRNA p5549表达水平显著升高(升高倍数:4.63±7.68,p = 0.014)。

结论

肥胖患者的表观遗传变化,特别是lncRNA - p5549表达水平,在MBS后得到逆转。lncRNA - p19461表达水平的术后升高无统计学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ba/11717812/e6527bfc1605/11695_2024_7596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ba/11717812/e6527bfc1605/11695_2024_7596_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0ba/11717812/e6527bfc1605/11695_2024_7596_Fig1_HTML.jpg

相似文献

1
Changes in Circulating Levels of Long Non-Coding RNA p5549 and p19461 Following Metabolic Bariatric Surgery (MBS): A Prospective Study.代谢性减肥手术后循环中长链非编码RNA p5549和p19461水平的变化:一项前瞻性研究
Obes Surg. 2025 Jan;35(1):131-140. doi: 10.1007/s11695-024-07596-5. Epub 2024 Dec 9.
2
Differentially expressed circulating LncRNAs and mRNA identified by microarray analysis in obese patients.通过微阵列分析在肥胖患者中鉴定出的差异表达的循环长链非编码RNA和信使核糖核酸
Sci Rep. 2016 Oct 21;6:35421. doi: 10.1038/srep35421.
3
Influence of Weight Loss on Obesity-Associated Complications After Metabolic and Bariatric Surgery in Adolescents.减肥对青少年代谢和减重手术后肥胖相关并发症的影响。
Obesity (Silver Spring). 2020 Dec;28(12):2397-2404. doi: 10.1002/oby.23038.
4
The effects of bariatric surgery on clinical profile, DNA methylation, and ageing in severely obese patients.肥胖症患者接受减重手术后对临床特征、DNA 甲基化和衰老的影响。
Clin Epigenetics. 2020 Jan 20;12(1):14. doi: 10.1186/s13148-019-0790-2.
5
Twelve-Month Outcomes after Metabolic and Bariatric Surgery among Youths Participating in a Structured Preparation and Follow-Up Program: Results of the Youth with Extreme Obesity Study.参与结构化准备和随访计划的青少年接受代谢和减重手术后的 12 个月结果:极度肥胖青少年研究的结果。
Obes Facts. 2024;17(1):59-71. doi: 10.1159/000535104. Epub 2023 Dec 11.
6
The Impact of Metabolic and Bariatric Surgery on Apo B100 Levels in Individuals with high BMI: A Multi-Centric Prospective Cohort Study.代谢与减重手术对高体重指数个体载脂蛋白B100水平的影响:一项多中心前瞻性队列研究。
Obes Surg. 2024 Jul;34(7):2454-2466. doi: 10.1007/s11695-024-07258-6. Epub 2024 May 15.
7
The Effect of Metabolic and Bariatric Surgery on DNA Methylation Patterns.代谢和减重手术对 DNA 甲基化模式的影响。
Curr Atheroscler Rep. 2017 Aug 30;19(10):40. doi: 10.1007/s11883-017-0676-8.
8
Effect of Bariatric Surgery on the Sonographic Grade of Metabolic-Associated Fatty Liver Disease at 12-Month Follow-Up.减重手术对代谢相关脂肪性肝病超声严重程度 12 个月随访的影响。
Obes Surg. 2024 Aug;34(8):2974-2979. doi: 10.1007/s11695-024-07376-1. Epub 2024 Jul 3.
9
Bariatric surgery-induced weight loss and associated genome-wide DNA-methylation alterations in obese individuals.肥胖个体接受减重手术引起的体重减轻与全基因组 DNA 甲基化改变。
Clin Epigenetics. 2022 Dec 18;14(1):176. doi: 10.1186/s13148-022-01401-9.
10
Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/m: are the Results After Balloon Related to Global Outcomes After Surgery?胃内球囊作为 BMI≥50kg/m2 的患者代谢减重手术前的第一步:球囊后的结果是否与手术后的总体结果相关?
Obes Surg. 2024 Sep;34(9):3195-3202. doi: 10.1007/s11695-024-07418-8. Epub 2024 Jul 23.

本文引用的文献

1
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.司美格鲁肽每周一次治疗 2 型糖尿病患者的肥胖症(SURMOUNT-2):一项双盲、随机、多中心、安慰剂对照、3 期临床试验。
Lancet. 2023 Aug 19;402(10402):613-626. doi: 10.1016/S0140-6736(23)01200-X. Epub 2023 Jun 26.
2
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation.肥胖症的药物治疗:现有药物及正在研究的药物的最新情况
EClinicalMedicine. 2023 Mar 20;58:101882. doi: 10.1016/j.eclinm.2023.101882. eCollection 2023 Apr.
3
2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.
2022年美国代谢与减重外科学会(ASMBS)和国际肥胖与代谢病外科联盟(IFSO):代谢与减重手术的适应证
Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013. Epub 2022 Oct 21.
4
The Australian Obesity Management Algorithm: A simple tool to guide the management of obesity in primary care.澳大利亚肥胖管理算法:一个指导初级保健中肥胖管理的简单工具。
Obes Res Clin Pract. 2022 Sep-Oct;16(5):353-363. doi: 10.1016/j.orcp.2022.08.003. Epub 2022 Aug 30.
5
The genetics of obesity: from discovery to biology.肥胖的遗传学:从发现到生物学。
Nat Rev Genet. 2022 Feb;23(2):120-133. doi: 10.1038/s41576-021-00414-z. Epub 2021 Sep 23.
6
Diabetes remission after bariatric surgery.减重手术后的糖尿病缓解
World J Diabetes. 2021 Jul 15;12(7):1093-1101. doi: 10.4239/wjd.v12.i7.1093.
7
Epigenetic regulation of energy metabolism in obesity.肥胖中能量代谢的表观遗传调控。
J Mol Cell Biol. 2021 Oct 21;13(7):480-499. doi: 10.1093/jmcb/mjab043.
8
Suppression of circulating long non-coding RNA in obese patients with breast cancer.肥胖乳腺癌患者循环长链非编码RNA的抑制
Oncol Lett. 2021 Jul;22(1):508. doi: 10.3892/ol.2021.12769. Epub 2021 May 3.
9
Pharmacotherapy of obesity: An update.肥胖的药物治疗:最新进展。
Pharmacol Res. 2021 Jul;169:105649. doi: 10.1016/j.phrs.2021.105649. Epub 2021 May 4.
10
Effects of bariatric surgery on lipid-lipoprotein profile.减重手术对血脂脂蛋白谱的影响。
Metabolism. 2021 Feb;115:154441. doi: 10.1016/j.metabol.2020.154441. Epub 2020 Nov 25.